drugset / Trial / NCT02227797
MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients
NaSingle-groupOpen-labelTreatment
Summary
The primary purpose of this study is to identify the optimal dose of voriconazole, an anti-fungal drug often used in people undergoing stem cell transplant. An optimal dose level is one level that provides a good blood level (concentration) of voriconazole without too much toxicity.
Timeline
- Start
- 2015-01-19
- Primary completion
- 2017-09-08
- Completion
- 2019-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Voriconazole | Small molecule | 6 mg/kg | Intravenous |
| Subject | Voriconazole | Small molecule | 12 mg/kg | Intravenous |